Cargando…
Ultra-Rapid-Acting Insulins: How Fast Is Really Needed?
OBJECTIVE. To review the new ultra-rapid-acting insulin analogs and describe the benefits and limitations compared with other bolus insulins. SUMMARY. The options for bolus insulins, which are usually taken at mealtime or for correction of hyperglycemia, are expanding, with recent approvals of faste...
Autores principales: | Wong, Eva Y., Kroon, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603316/ https://www.ncbi.nlm.nih.gov/pubmed/34866783 http://dx.doi.org/10.2337/cd20-0119 |
Ejemplares similares
-
Insulin Regulates Brain Function, but How Does It Get There?
por: Gray, Sarah M., et al.
Publicado: (2014) -
CopenFast trial: Faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy and lactation - a randomised controlled trial
por: Nørgaard, Sidse Kjærhus, et al.
Publicado: (2021) -
Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials
por: Lim, Beng Leong, et al.
Publicado: (2023) -
Acylcarnitines: Reflecting or Inflicting Insulin Resistance?
por: Schooneman, Marieke G., et al.
Publicado: (2013) -
Closing in on the Mechanisms of Pulsatile Insulin Secretion
por: Bertram, Richard, et al.
Publicado: (2018)